🇺🇸 FDA
Patent

US 8877914

Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

granted A61KA61K2039/5158A61K2039/53

Quick answer

US patent 8877914 (Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/5158, A61K2039/53, A61K2039/54, A61K2039/545